annual CFO:
-$462.85M-$308.96M(-200.77%)Summary
- As of today (June 22, 2025), ARWR annual cash flow from operations is -$462.85 million, with the most recent change of -$308.96 million (-200.77%) on September 30, 2024.
- During the last 3 years, ARWR annual CFO has fallen by -$634.16 million (-370.18%).
- ARWR annual CFO is now -367.49% below its all-time high of $173.03 million, reached on September 30, 2019.
Performance
ARWR Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$460.05M+$606.33M(+414.52%)Summary
- As of today (June 22, 2025), ARWR quarterly cash flow from operations is $460.05 million, with the most recent change of +$606.33 million (+414.52%) on March 31, 2025.
- Over the past year, ARWR quarterly CFO has increased by +$552.43 million (+598.02%).
- ARWR quarterly CFO is now at all-time high.
Performance
ARWR quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$61.15M+$552.43M(+112.45%)Summary
- As of today (June 22, 2025), ARWR TTM cash flow from operations is $61.15 million, with the most recent change of +$552.43 million (+112.45%) on March 31, 2025.
- Over the past year, ARWR TTM CFO has increased by +$318.07 million (+123.80%).
- ARWR TTM CFO is now -66.78% below its all-time high of $184.08 million, reached on June 30, 2021.
Performance
ARWR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ARWR Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -200.8% | +598.0% | +123.8% |
| 3 y3 years | -370.2% | +633.4% | +217.1% |
| 5 y5 years | -367.5% | +1767.8% | +328.4% |
ARWR Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -370.2% | at low | at high | +414.5% | at high | +112.5% |
| 5 y | 5-year | -367.5% | at low | at high | +414.5% | -66.8% | +112.5% |
| alltime | all time | -367.5% | at low | at high | +414.5% | -66.8% | +112.5% |
ARWR Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $460.05M(-414.5%) | $61.15M(-112.4%) |
| Dec 2024 | - | -$146.27M(+6.6%) | -$491.28M(+6.1%) |
| Sep 2024 | -$462.85M(+200.8%) | -$137.22M(+18.9%) | -$462.85M(+31.7%) |
| Jun 2024 | - | -$115.42M(+24.9%) | -$351.56M(+36.8%) |
| Mar 2024 | - | -$92.38M(-21.6%) | -$256.92M(+30.9%) |
| Dec 2023 | - | -$117.84M(+354.5%) | -$196.21M(+27.5%) |
| Sep 2023 | -$153.89M(+13.0%) | -$25.93M(+24.8%) | -$153.89M(-21.8%) |
| Jun 2023 | - | -$20.78M(-34.4%) | -$196.70M(-19.6%) |
| Mar 2023 | - | -$31.67M(-58.1%) | -$244.74M(+62.8%) |
| Dec 2022 | - | -$75.52M(+9.9%) | -$150.34M(+10.4%) |
| Sep 2022 | -$136.13M(-179.5%) | -$68.74M(-0.1%) | -$136.13M(+48.9%) |
| Jun 2022 | - | -$68.81M(-209.7%) | -$91.42M(+75.1%) |
| Mar 2022 | - | $62.73M(-202.3%) | -$52.22M(-135.1%) |
| Dec 2021 | - | -$61.31M(+155.1%) | $148.93M(-13.1%) |
| Sep 2021 | $171.31M(-278.8%) | -$24.03M(-18.8%) | $171.31M(-6.9%) |
| Jun 2021 | - | -$29.61M(-111.2%) | $184.08M(+2.1%) |
| Mar 2021 | - | $263.87M(-778.0%) | $180.26M(-262.1%) |
| Dec 2020 | - | -$38.92M(+245.7%) | -$111.19M(+16.1%) |
| Sep 2020 | -$95.80M(-155.4%) | -$11.26M(-66.3%) | -$95.80M(+35.4%) |
| Jun 2020 | - | -$33.43M(+21.2%) | -$70.73M(+164.1%) |
| Mar 2020 | - | -$27.59M(+17.2%) | -$26.78M(+42.6%) |
| Dec 2019 | - | -$23.53M(-270.4%) | -$18.78M(-110.9%) |
| Sep 2019 | $173.03M(-466.4%) | $13.81M(+31.2%) | $173.04M(+10.5%) |
| Jun 2019 | - | $10.53M(-153.7%) | $156.54M(+18.9%) |
| Mar 2019 | - | -$19.59M(-111.6%) | $131.61M(-3.1%) |
| Dec 2018 | - | $168.28M(-6378.6%) | $135.75M(-387.5%) |
| Sep 2018 | -$47.22M(+97.3%) | -$2.68M(-81.4%) | -$47.22M(-12.1%) |
| Jun 2018 | - | -$14.41M(-6.7%) | -$53.75M(+8.0%) |
| Mar 2018 | - | -$15.44M(+5.1%) | -$49.75M(+2.3%) |
| Dec 2017 | - | -$14.69M(+59.6%) | -$48.63M(+103.1%) |
| Sep 2017 | -$23.94M(-62.8%) | -$9.20M(-11.6%) | -$23.94M(-3.9%) |
| Jun 2017 | - | -$10.41M(-27.3%) | -$24.92M(-24.2%) |
| Mar 2017 | - | -$14.33M(-243.3%) | -$32.86M(-1.3%) |
| Dec 2016 | - | $10.00M(-198.2%) | -$33.28M(-48.3%) |
| Sep 2016 | -$64.43M(-1.9%) | -$10.18M(-44.5%) | -$64.43M(-2.8%) |
| Jun 2016 | - | -$18.35M(+24.4%) | -$66.27M(+8.6%) |
| Mar 2016 | - | -$14.75M(-30.3%) | -$61.03M(-2.6%) |
| Dec 2015 | - | -$21.15M(+75.9%) | -$62.66M(-4.6%) |
| Sep 2015 | -$65.71M(+85.5%) | -$12.02M(-8.4%) | -$65.71M(+1.7%) |
| Jun 2015 | - | -$13.12M(-19.9%) | -$64.61M(+5.5%) |
| Mar 2015 | - | -$16.37M(-32.4%) | -$61.27M(+16.5%) |
| Dec 2014 | - | -$24.20M(+121.6%) | -$52.59M(+48.5%) |
| Sep 2014 | -$35.42M(+86.1%) | -$10.92M(+11.7%) | -$35.42M(+18.5%) |
| Jun 2014 | - | -$9.78M(+27.0%) | -$29.89M(+17.5%) |
| Mar 2014 | - | -$7.70M(+9.6%) | -$25.45M(+14.5%) |
| Dec 2013 | - | -$7.02M(+30.2%) | -$22.22M(+16.7%) |
| Sep 2013 | -$19.03M(+24.1%) | -$5.39M(+1.1%) | -$19.03M(+4.4%) |
| Jun 2013 | - | -$5.33M(+19.4%) | -$18.23M(+8.6%) |
| Mar 2013 | - | -$4.47M(+16.4%) | -$16.78M(+1.9%) |
| Dec 2012 | - | -$3.84M(-16.4%) | -$16.47M(+7.4%) |
| Sep 2012 | -$15.34M | -$4.59M(+18.0%) | -$15.34M(+23.6%) |
| Jun 2012 | - | -$3.89M(-6.5%) | -$12.42M(+30.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$4.16M(+53.7%) | -$9.55M(+43.1%) |
| Dec 2011 | - | -$2.71M(+62.7%) | -$6.67M(+23.8%) |
| Sep 2011 | -$5.39M(-30.0%) | -$1.66M(+62.4%) | -$5.39M(-13.6%) |
| Jun 2011 | - | -$1.02M(-20.0%) | -$6.24M(-10.8%) |
| Mar 2011 | - | -$1.28M(-10.1%) | -$6.99M(-6.6%) |
| Dec 2010 | - | -$1.42M(-43.3%) | -$7.49M(-2.7%) |
| Sep 2010 | -$7.70M(-49.6%) | -$2.51M(+41.3%) | -$7.70M(+1.3%) |
| Jun 2010 | - | -$1.78M(+0.2%) | -$7.60M(+4.0%) |
| Mar 2010 | - | -$1.77M(+8.6%) | -$7.31M(-28.4%) |
| Dec 2009 | - | -$1.63M(-32.4%) | -$10.21M(-33.2%) |
| Sep 2009 | -$15.28M(-44.6%) | -$2.42M(+62.8%) | -$15.28M(-28.1%) |
| Jun 2009 | - | -$1.48M(-68.3%) | -$21.25M(-22.5%) |
| Mar 2009 | - | -$4.68M(-30.1%) | -$27.42M(-3.6%) |
| Dec 2008 | - | -$6.70M(-20.1%) | -$28.45M(+3.1%) |
| Sep 2008 | -$27.58M(+15.6%) | -$8.38M(+9.5%) | -$27.58M(+7.3%) |
| Jun 2008 | - | -$7.65M(+34.0%) | -$25.70M(+8.5%) |
| Mar 2008 | - | -$5.71M(-2.0%) | -$23.68M(-3.8%) |
| Dec 2007 | - | -$5.83M(-10.2%) | -$24.61M(+3.1%) |
| Sep 2007 | -$23.87M(+61.4%) | -$6.50M(+15.3%) | -$23.87M(+13.5%) |
| Jun 2007 | - | -$5.64M(-15.1%) | -$21.03M(+5.7%) |
| Mar 2007 | - | -$6.64M(+30.5%) | -$19.90M(+19.2%) |
| Dec 2006 | - | -$5.09M(+38.9%) | -$16.69M(+12.9%) |
| Sep 2006 | -$14.79M(+62.6%) | -$3.66M(-18.7%) | -$14.79M(+7.9%) |
| Jun 2006 | - | -$4.51M(+31.3%) | -$13.71M(+13.0%) |
| Mar 2006 | - | -$3.43M(+7.6%) | -$12.14M(+17.4%) |
| Dec 2005 | - | -$3.19M(+23.3%) | -$10.34M(+13.7%) |
| Sep 2005 | -$9.10M(+293.2%) | -$2.59M(-11.9%) | -$9.10M(+26.1%) |
| Jun 2005 | - | -$2.93M(+79.6%) | -$7.21M(+41.6%) |
| Mar 2005 | - | -$1.63M(-16.1%) | -$5.09M(+29.3%) |
| Dec 2004 | - | -$1.95M(+178.0%) | -$3.94M(+70.2%) |
| Sep 2004 | -$2.31M(+1368.5%) | -$700.00K(-14.2%) | -$2.31M(+35.3%) |
| Jun 2004 | - | -$815.40K(+70.3%) | -$1.71M(+89.5%) |
| Mar 2004 | - | -$478.80K(+49.5%) | -$902.80K(+95.5%) |
| Dec 2003 | - | -$320.20K(+232.5%) | -$461.90K(+193.1%) |
| Sep 2003 | -$157.60K(+49.0%) | -$96.30K(+1184.0%) | -$157.60K(+109.0%) |
| Jun 2003 | - | -$7500.00(-80.2%) | -$75.40K(-35.5%) |
| Mar 2003 | - | -$37.90K(+138.4%) | -$116.90K(+23.2%) |
| Dec 2002 | - | -$15.90K(+12.8%) | -$94.90K(-10.4%) |
| Sep 2002 | -$105.80K(+29.3%) | -$14.10K(-71.2%) | -$105.90K(-0.6%) |
| Jun 2002 | - | -$49.00K(+208.2%) | -$106.50K(+46.1%) |
| Mar 2002 | - | -$15.90K(-40.9%) | -$72.90K(-18.9%) |
| Dec 2001 | - | -$26.90K(+83.0%) | -$89.90K(+9.8%) |
| Sep 2001 | -$81.80K(+2.1%) | -$14.70K(-4.5%) | -$81.90K(-7.2%) |
| Jun 2001 | - | -$15.40K(-53.2%) | -$88.30K(-34.3%) |
| Mar 2001 | - | -$32.90K(+74.1%) | -$134.30K(+33.9%) |
| Dec 2000 | - | -$18.90K(-10.4%) | -$100.30K(+25.1%) |
| Sep 2000 | -$80.10K(+127.6%) | -$21.10K(-65.6%) | -$80.20K(+35.7%) |
| Jun 2000 | - | -$61.40K(-5681.8%) | -$59.10K(-2669.6%) |
| Mar 2000 | - | $1100.00(-8.3%) | $2300.00(+91.7%) |
| Dec 1999 | - | $1200.00 | $1200.00 |
| Sep 1999 | -$35.20K(<-9900.0%) | - | - |
| Sep 1998 | $100.00(-97.8%) | - | - |
| Sep 1997 | $4600.00 | - | - |
FAQ
- What is Arrowhead Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual CFO year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly CFO year-on-year change?
- What is Arrowhead Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals TTM CFO year-on-year change?
What is Arrowhead Pharmaceuticals annual cash flow from operations?
The current annual CFO of ARWR is -$462.85M
What is the all time high annual CFO for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual cash flow from operations is $173.03M
What is Arrowhead Pharmaceuticals annual CFO year-on-year change?
Over the past year, ARWR annual cash flow from operations has changed by -$308.96M (-200.77%)
What is Arrowhead Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ARWR is $460.05M
What is the all time high quarterly CFO for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly cash flow from operations is $460.05M
What is Arrowhead Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ARWR quarterly cash flow from operations has changed by +$552.43M (+598.02%)
What is Arrowhead Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ARWR is $61.15M
What is the all time high TTM CFO for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high TTM cash flow from operations is $184.08M
What is Arrowhead Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ARWR TTM cash flow from operations has changed by +$318.07M (+123.80%)